Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan

Cardiovascular Intervention and Therapeutics

Volumn 26, Issue 3, 2011, Pages 234-245

  Kimura, Takeshi ^a   Morimoto, Takeshi ^b   Furukawa, Yutaka ^c   Nakagawa, Yoshihisa ^d   Kadota, Kazushige ^e   Iwabuchi, Masashi ^f   Shizuta, Satoshi ^a   Shiomi, Hiroki ^a   Tada, Tomohisa ^a   Tazaki, Junichi ^a   Kato, Yoshihiro ^a   Hayano, Mamoru ^a   Abe, Mitsuru ^g   Tamura, Takashi ^h   Shirotani, Manabu ⁱ   Miki, Shinji ^j   Matsuda, Mitsuo ^k   Takahashi, Mamoru ^l   Ishii, Katsuhisa ^m   Tanaka, Masaru ⁿ   Aoyama, Takeshi ^o   Doi, Osamu ^p   Hattori, Ryuichi ^o   Tatami, Ryozo ^q   Suwa, Satoru ^r   Takizawa, Akinori ^s   Takatsu, Yoshiki ^t   Takahashi, Masaaki ^u   Kato, Hiroshi ^v   Takeda, Teruki ^w   Lee, Jong Dae ^x   Nohara, Ryuji ^y   Ogawa, Hisao ^z   Tei, Chuwa ^aa   Horie, Minoru ^ab   Kambara, Hirofumi ^p   Fujiwara, Hisayoshi ^t   Mitsudo, Kazuaki ^e   Nobuyoshi, Masakiyo ^f   Kita, Toru ^c   more..

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d TENRI HOSPITAL   (Japan)

^e KURASHIKI CENTRAL HOSPITAL   (Japan)

^f KOKURA MEMORIAL HOSPITAL   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^h JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

ⁱ KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j MITSUBISHI KYOTO HOSPITAL   (Japan)

^k Kishiwada City Hospital   (Japan)

^l Shimabara Hospital   (Japan)

^m Kansai Denryoku Hospital   (Japan)

ⁿ OSAKA RED CROSS HOSPITAL   (Japan)

^o SHIMADA MUNICIPAL HOSPITAL   (Japan)

^p SHIZUOKA GENERAL HOSPITAL   (Japan)

^q Maizuru Kyosai Hospital   (Japan)

^r JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^s SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^t HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^u HAMAMATSU ROSAI HOSPITAL   (Japan)

^v NISHI KOBE MEDICAL CENTER   (Japan)

^w Department of Neurosurgery   (Japan)

^x UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^y Kitano Hospital   (Japan)

^z KUMAMOTO UNIVERSITY   (Japan)

^aa KAGOSHIMA UNIVERSITY   (Japan)

^ab SHIGA UNIVERSITY OF MEDICAL SCIENCE HOSPITAL   (Japan)

more..

Author keywords

Restenosis; Stents; Thrombus

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; RAPAMYCIN; TICLOPIDINE;

ACUTE HEART INFARCTION; AGED; ARTICLE; BARE METAL STENT; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DISEASE REGISTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; INFARCTION; JAPAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT DURATION;

EID: 84860481375     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-011-0065-0     Document Type: Article

References (21)

1. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21.
2. Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med. 2007; 356: 1009-19.
3. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007; 369: 667-78.
4. Pfisterer M, Brunner-La Rocca HP, Buser PT, Rickenbacher P, Hunziker P, Mueller C, BASKET-LATE Investigators, et al. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2006; 48: 2584-91.
5. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: comparative meta-analysis of randomized trials and observational studies. Circulation. 2009; 119: 3198-206.
6. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, et al. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007; 357: 1393-402.
7. Mauri L, Silbaugh TS, Wolf RE, Zelevinsky K, Lovett A, Zhou Z, et al. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation. 2008; 118: 1817-27.
8. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent: data from an observational cohort study of drug-eluting versus bare-metal stents. J Am Coll Cardiol Interv. 2008; 1: 494-503.
9. Shishehbor MH, Goel SS, Kapadia SR, Bhatt DL, Kelly P, Raymond RE, et al. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol. 2008; 52: 1041-8.
10. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, et al. Long-Term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation. 2008; 118: S199-209.
11. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009; 53: 932-5.
12. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene A, Bonnier JJ, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46: 575-81.
13. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med. 2007; 356: 1020-9.
14. The GUSTO Investigators. An inter-national randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993; 329: 673-82.
15. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation. 2009; 119: 987-95.
16. Bar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol. 2009; 53: 1677-89.
17. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009; 360: 1946-59.
18. Steg PG, Fox KA, Eagle KA, Furman M, van de Werf F, Montalescot G, et al. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J. 2009; 30: 321-9.
19. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial Healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008; 118: 1138-45.
20. Wenaweser P, Daeman J, Zwahlen M, van Domburg R, Juni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol. 2008; 52: 1134-40.
21. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol. 2010; 106: 329-36.